一种实验性流感亚单位疫苗（免疫刺激复合物）：经鼻内或皮下接种后在小鼠中诱导对攻击感染的保护性免疫。
An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration.
作者信息
Lövgren K, Kåberg H, Morein B
机构信息
National Veterinary Institute, Department of Virology, Uppsala, Sweden.
出版信息
Clin Exp Immunol. 1990 Dec;82(3):435-9. doi: 10.1111/j.1365-2249.1990.tb05467.x.
Abstract
An experimental influenza virus (A/PR/8/34(H1N1] vaccine was tested and evaluated in mice. The mice were inoculated once or twice intranasally or subcutaneously with 1 or 10 micrograms of iscoms prior to challenge with high dose of live virus. It was demonstrated that two intranasal administrations were as efficient as two s.c. administrations, both routes inducing high levels of antibody and protection against challenge infection. With a one-dose regimen, the s.c. route induced a somewhat higher antibody response than the intranasal route; this might be explained by technical difficulties connected with an intranasal administration.
摘要
一种实验性流感病毒（A/PR/8/34[H1N1]）疫苗在小鼠身上进行了测试和评估。在以高剂量活病毒进行攻击之前，给小鼠经鼻内或皮下接种1或10微克免疫刺激复合物，接种一次或两次。结果表明，两次鼻内给药与两次皮下给药效果相同，两种途径均能诱导高水平抗体并提供针对攻击感染的保护。采用单剂量方案时，皮下途径诱导的抗体反应略高于鼻内途径；这可能是由于鼻内给药存在技术困难所致。
相似文献
1
An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration.一种实验性流感亚单位疫苗（免疫刺激复合物）：经鼻内或皮下接种后在小鼠中诱导对攻击感染的保护性免疫。
Clin Exp Immunol. 1990 Dec;82(3):435-9. doi: 10.1111/j.1365-2249.1990.tb05467.x.
2
Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.细菌样颗粒佐以灭活流感抗原经鼻内给药诱导交叉保护性流感特异性抗体应答。
Vaccine. 2012 Jul 6;30(32):4884-91. doi: 10.1016/j.vaccine.2012.04.032. Epub 2012 Apr 23.
3
Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.免疫刺激复合物（ISCOMs）、脂质体和弗氏完全佐剂（FCA）对局部和全身体液免疫反应的免疫增强作用：在小鼠抗甲型流感病毒感染中的作用
Vaccine. 1993 Oct;11(13):1302-9. doi: 10.1016/0264-410x(93)90099-j.
4
Comparative antibody responses and protection in mice immunised by oral or parenteral routes with influenza virus subunit antigens in aqueous form or incorporated into ISCOMs.通过口服或肠胃外途径用呈水性形式或掺入免疫刺激复合物（ISCOM）中的流感病毒亚单位抗原免疫的小鼠的抗体反应比较及保护作用
J Med Microbiol. 1995 Jan;42(1):53-61. doi: 10.1099/00222615-42-1-53.
5
Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.弹性蛋白酶依赖的活减毒猪流感病毒疫苗经鼻腔免疫接种诱导的猪的免疫原性和保护效力。
Vaccine. 2010 Oct 8;28(43):7098-108. doi: 10.1016/j.vaccine.2010.08.003. Epub 2010 Aug 12.
6
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.通过鼻内共同给予杆状病毒表面展示的血凝素（HA）和重组霍乱毒素B亚单位（CTB）作为佐剂，对小鼠进行针对H5N1流感病毒攻击的保护性免疫。
Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.
7
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.新型活流感疫苗M2SR可保护小鼠和雪貂免受高致病性禽流感的侵害。
Vaccine. 2017 Jul 24;35(33):4177-4183. doi: 10.1016/j.vaccine.2017.06.039. Epub 2017 Jun 28.
8
9
The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes.流感病毒免疫刺激复合物经鼻内和皮下免疫后血清抗体反应在亚类和同种型中的分布情况。
Scand J Immunol. 1988 Feb;27(2):241-5. doi: 10.1111/j.1365-3083.1988.tb02343.x.
10
Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.壳聚糖作为佐剂经鼻腔给予 M1 基疫苗对流感病毒感染的交叉保护作用。
Vaccine. 2010 Nov 10;28(48):7690-8. doi: 10.1016/j.vaccine.2010.09.019. Epub 2010 Sep 24.
引用本文的文献
1
Potentials of saponins-based adjuvants for nasal vaccines.基于皂苷佐剂的鼻腔疫苗的潜力。
Front Immunol. 2023 Mar 20;14:1153042. doi: 10.3389/fimmu.2023.1153042. eCollection 2023.
2
Protection Generated by Prior Exposure to Pathogens Depends on both Priming and Challenge Dose.先前暴露于病原体产生的保护作用取决于激发剂量和挑战剂量。
Infect Immun. 2022 Mar 17;90(3):e0053721. doi: 10.1128/IAI.00537-21. Epub 2022 Jan 18.
3
Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice.在老龄近交系和远交系小鼠中，使用黏膜佐剂N3和表达鞭毛蛋白的DNA质粒进行鼻腔全流感免疫，可显著延长对甲型流感病毒的持久黏膜和全身免疫，并具有保护作用。
Vaccines (Basel). 2019 Jul 16;7(3):64. doi: 10.3390/vaccines7030064.
4
Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection.脂质体：用于感染性黏膜疫苗接种的多功能递药系统。
Front Immunol. 2018 Mar 7;9:431. doi: 10.3389/fimmu.2018.00431. eCollection 2018.
5
Mouse models for the study of mucosal vaccination against otitis media.用于研究中耳炎黏膜疫苗接种的小鼠模型。
Vaccine. 2008 Mar 17;26(12):1501-24. doi: 10.1016/j.vaccine.2008.01.029. Epub 2008 Feb 4.
6
Cowpea mosaic virus as a vaccine carrier of heterologous antigens.豇豆花叶病毒作为异源抗原的疫苗载体。
Mol Biotechnol. 2001 Jan;17(1):15-26. doi: 10.1385/MB:17:1:15.
7
Respiratory viral infections in the elderly.老年人的呼吸道病毒感染
Antiviral Res. 1999 Dec 15;44(2):79-102. doi: 10.1016/s0166-3542(99)00062-5.
8
Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.经鼻或口服给予嵌合植物病毒颗粒可在小鼠体内诱导全身和黏膜免疫反应。
J Virol. 1999 Feb;73(2):930-8. doi: 10.1128/JVI.73.2.930-938.1999.
9
Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice.靶向主要组织相容性复合体II类分子的鼻内抗原引发小鼠局部IgA和血清IgG抗体反应。
Immunology. 1997 Mar;90(3):323-9. doi: 10.1111/j.1365-2567.1997.00323.x.
10
Novel adjuvants and vaccine delivery systems.新型佐剂与疫苗递送系统。
Vet Immunol Immunopathol. 1996 Nov;54(1-4):373-84. doi: 10.1016/s0165-2427(96)05697-8.
本文引用的文献
1
N-D-Gluco-N-methylalkanamide compounds, a new class of non-ionic detergents for membrane biochemistry.N-D-葡萄糖-N-甲基链烷酰胺化合物，一类用于膜生物化学的新型非离子洗涤剂。
Biochem J. 1982 Nov 1;207(2):363-6. doi: 10.1042/bj2070363.
2
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection.副粘病毒融合糖蛋白抗体在预防感染传播中的重要性。
J Exp Med. 1980 Feb 1;151(2):275-88. doi: 10.1084/jem.151.2.275.
3
Solubilization and reconstitution of membrane proteins of Escherichia coli using alkanoyl-N-methylglucamides.使用链烷酰-N-甲基葡糖酰胺对大肠杆菌膜蛋白进行增溶和复性
J Biochem. 1984 May;95(5):1349-53. doi: 10.1093/oxfordjournals.jbchem.a134742.
4
Influenza virus ISCOMs: antibody response in animals.流感病毒免疫刺激复合物：动物体内的抗体反应
Vaccine. 1988 Feb;6(1):49-53. doi: 10.1016/0264-410x(88)90014-x.
5
The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes.流感病毒免疫刺激复合物经鼻内和皮下免疫后血清抗体反应在亚类和同种型中的分布情况。
Scand J Immunol. 1988 Feb;27(2):241-5. doi: 10.1111/j.1365-3083.1988.tb02343.x.
6
Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).
Scand J Immunol. 1988 Jun;27(6):645-52. doi: 10.1111/j.1365-3083.1988.tb02397.x.
7
Measles virus fusion protein presented in an immune-stimulating complex (iscom) induces haemolysis-inhibiting and fusion-inhibiting antibodies, virus-specific T cells and protection in mice.呈递于免疫刺激复合物（iscom）中的麻疹病毒融合蛋白可诱导小鼠产生抑制溶血和抑制融合的抗体、病毒特异性T细胞并提供保护作用。
J Gen Virol. 1988 Mar;69 ( Pt 3):549-59. doi: 10.1099/0022-1317-69-3-549.
8
9
Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.含血凝素或融合蛋白的免疫刺激复合物对小鼠致命性麻疹病毒感染的保护作用。
J Virol. 1987 Dec;61(12):3896-901. doi: 10.1128/JVI.61.12.3896-3901.1987.
10
Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
J Gen Virol. 1988 Aug;69 ( Pt 8):2093-6. doi: 10.1099/0022-1317-69-8-2093.
Zotero 插件